-
Abend JR, Uldrick T, Ziegelbauer JM, 2010: Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression[J]. J Virol, 84, 12139-12151. doi: 10.1128/JVI.00884-10
-
Abend JR, Ramalingam D, Kieffer-Kwon P, Uldrick TS, Yarchoan R, Ziegelbauer JM, 2012: Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression[J]. J Virol, 86, 11663-11674. doi: 10.1128/JVI.01147-12
-
Adams V, Kempf W, Hassam S, Briner J, Schmid M, Moos R, Pfaltz M, 1995: Detection of several types of human papilloma viruses in AIDS-associated Kaposi's sarcoma[J]. J Med Virol, 46, 189-193. doi: 10.1002/(ISSN)1096-9071
-
Ajiro M, Zheng ZM, 2014: Oncogenes and RNA splicing of human tumor viruses[J]. Emerg Microbes Infect, 3, e63-.
-
Akula SM, Pramod NP, Wang FZ, Chandran B, 2001: Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties[J]. Virology, 284, 235-249. doi: 10.1006/viro.2001.0921
-
Akula SM, Pramod NP, Wang F, Chandran B, 2002: Integrin α3/β1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells[J]. Cell, 108, 407-419. doi: 10.1016/S0092-8674(02)00628-1
-
Al-Kzayer LF, Keizer P, Abdulraheem FT, Sano K, Kamata M, Sakashita K, Habbaba LA, Koike K, 2016: Rapidly progressive Kaposi's Sarcoma in an Iraqi boy received valproic acid: a case report and review of literature[J]. BMC Pediatr, 16, 111-. doi: 10.1186/s12887-016-0653-3
-
Ameres SL, Zamore PD, 2013: Diversifying microRNA sequence and function[J]. Nat Rev Mol Cell Biol, 14, 475-488. doi: 10.1038/nrm3611
-
Andrei G, Snoeck R, 2015: Kaposi's sarcoma-associated herpesvirus: the role of lytic replication in targeted therapy[J]. Curr Opin Infect Dis, 28, 611-624. doi: 10.1097/QCO.0000000000000213
-
Areste C, Blackbourn DJ, 2009: Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus[J]. Trends Microbiol, 17, 119-129. doi: 10.1016/j.tim.2008.12.001
-
Arias C, Welsberd B, Stern-Ginossar N, Mercier A, Madrid AS, Bellare P, Holdorf M, Weissman JS, Ganem D, 2014: KSHV 2.0: a comprehensive annotation of the Kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features[J]. PLoS Pathog, 10, e1003847-. doi: 10.1371/journal.ppat.1003847
-
Asou H, Said JW, Yang R, Munker R, Park DJ, Kamada N, Koeffler HP, 1998: Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells[J]. Blood, 91, 2475-2481.
-
Avitabile E, Forghieri C, Campadelli-Fiume G, 2009: Cross talk among the glycoproteins involved in herpes simplex virus entry and fusion: the interaction between gB and gH/gL does not necessarily require gD[J]. J Virol, 83, 10752-10760. doi: 10.1128/JVI.01287-09
-
Baghian A, Luftig M, Black JB, Meng YX, Pau CP, Voss T, Pellett PE, Kousoulas KG, 2000: Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino- and carboxyl-terminal fragments[J]. Virology, 269, 18-25. doi: 10.1006/viro.2000.0198
-
Bagneris C, Ageichik AV, Cronin N, Wallace B, Collins M, Boshoff C, Waksman G, Barrett T, 2008: Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome[J]. Mol Cell, 30, 620-631. doi: 10.1016/j.molcel.2008.04.029
-
Bajaj BG, Verma SC, Lan K, Cotter MA, Woodman ZL, Robertson ES, 2006: KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity[J]. Virology, 351, 18-28. doi: 10.1016/j.virol.2006.03.037
-
Ballestas ME, Kaye KM, 2001: Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA[J]. J Virol, 75, 3250-3258. doi: 10.1128/JVI.75.7.3250-3258.2001
-
Ballestas ME, Chatis PA, Kaye KM, 1999: Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen[J]. Science, 284, 641-644. doi: 10.1126/science.284.5414.641
-
Baresova P, Pitha PM, Lubyova B, 2013: Distinct roles of Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factors in inflammatory response and cancer[J]. J Virol, 87, 9398-9410. doi: 10.1128/JVI.03315-12
-
Bechtel JT, Winant RC, Ganem D, 2005: Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus[J]. J Virol, 79, 4952-4964. doi: 10.1128/JVI.79.8.4952-4964.2005
-
Bellare P, Ganem D, 2009: Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation[J]. Cell Host Microbe, 6, 570-575. doi: 10.1016/j.chom.2009.11.008
-
Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, Jaenisch R, Wagschal A, Feil R, Schreiber SL, Lander ES, 2006: A bivalent chromatin structure marks key developmental genes in embryonic stem cells[J]. Cell, 125, 315-326. doi: 10.1016/j.cell.2006.02.041
-
Bieleski L, Talbot SJ, 2001: Kaposi's sarcoma-associated herpesvirus vCyclin open reading frame contains an internal ribosome entry site[J]. J Virol, 75, 1864-1869. doi: 10.1128/JVI.75.4.1864-1869.2001
-
Boldogh I, Szaniszlo P, Bresnahan WA, Flaitz CM, Nichols MC, Albrecht T, 1996: Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus[J]. Clin Infect Dis, 23, 406-407. doi: 10.1093/clinids/23.2.406
-
Boshoff C, 2002: Kaposi's Sarcoma Biology[J]. IUBMB Life, 53, 259-261. doi: 10.1080/15216540212645
-
Botto S, Totonchy JE, Gustin JK, Moses AV, 2015: Kaposi sarcoma herpesvirus induces HO-1 during de novo infection of endothelial cells via viral miRNA-dependent and -independent mechanisms[J]. MBio, 6, e00668-.
-
Boyne JR, Colgan KJ, Whitehouse A, 2008: Recruitment of the complete hTREX complex is required for Kaposi's sarcoma-associated herpesvirus intronless mRNA nuclear export and virus replication[J]. PLoS Pathog, 4, e1000194-. doi: 10.1371/journal.ppat.1000194
-
Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, Toth Z, Lee SH, Lee HR, Myoung J, Ganem D, Oh TK, Kim JF, Gao SJ, Jung JU, 2012: Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone[J]. J Virol, 86, 9708-9720. doi: 10.1128/JVI.01019-12
-
Brulois K, Toth Z, Wong LY, Feng P, Gao SJ, Ensser A, Jung JU, 2014: Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication[J]. J Virol, 88, 9335-9349. doi: 10.1128/JVI.00873-14
-
Bu W, Palmeri D, Krishnan R, Marin R, Aris VM, Soteropoulos P, Lukac DM, 2008: Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization[J]. J Virol, 82, 10709-10723. doi: 10.1128/JVI.01012-08
-
Byun H, Gwack Y, Hwang S, Choe J, 2002: Kaposi's Sarcoma-associated herpesvirus open reading frame (ORF) 50 transactivates K8 and ORF57 promoters via heterogeneous response elements[J]. Mol Cells, 14, 185-191.
-
Cai X, Cullen BR, 2006: Transcriptional origin of Kaposi's sarcoma-associated herpesvirus microRNAs[J]. J Virol, 80, 2234-2242. doi: 10.1128/JVI.80.5.2234-2242.2006
-
Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR, 2005: Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells[J]. Proc Natl Acad Sci USA, 102, 5570-5575. doi: 10.1073/pnas.0408192102
-
Cai Q, Knight JS, Verma SC, Zald P, Robertson ES, 2006: EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors[J]. PLoS Pathog, 2, 1002-1012.
-
Cai Q, Verma SC, Lu J, Robertson ES, 2010: Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis[J]. Adv Virus Res, 78, 87-142. doi: 10.1016/B978-0-12-385032-4.00003-3
-
Campbell M, Izumiya Y, 2012: Post-translational modifications of Kaposi's sarcoma-associated herpesvirus regulatory proteins-SUMO and KSHV[J]. Front Microbiol, 3, 31-.
-
Campbell M, Chang PC, Huerta S, Izumiya C, Davis R, Tepper CG, Kim KY, Shevchenko B, Wang DH, Jung JU, Luciw PA, Kung HJ, Izumiya Y, 2012: Protein arginine methyltransferase 1-directed methylation of Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen[J]. J Biol Chem, 287, 5806-5818. doi: 10.1074/jbc.M111.289496
-
Cao Y, Minhas V, Tan X, Huang J, Wang B, Zhu M, Gao Y, Zhao T, Yang L, Wood C, 2014: High prevalence of early childhood infection by Kaposi's sarcoma-associated herpesvirus in a minority population in China[J]. Clin Microbiol Infect, 20, 475-481. doi: 10.1111/1469-0691.12340
-
Carroll KD, Khadim F, Spadavecchia S, Palmeri D, Lukac DM, 2007: Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation[J]. J Virol, 81, 8451-8467. doi: 10.1128/JVI.00265-07
-
Chandriani S, Ganem D, 2010: Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus[J]. J Virol, 84, 5565-5573. doi: 10.1128/JVI.02723-09
-
Chang PC, Li M, 2008: Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor[J]. J Virol, 82, 278-290. doi: 10.1128/JVI.01552-07
-
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS, 1994: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma[J]. Science, 266, 1865-1869. doi: 10.1126/science.7997879
-
Chang H, Wachtman LM, Pearson CB, Lee JS, Lee HR, Lee SH, Vieira J, Mansfield KG, Jung JU, 2009: Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection[J]. PLoS Pathog, 5, e1000606-. doi: 10.1371/journal.ppat.1000606
-
Chang HC, Hsieh TH, Lee YW, Tsai CF, Tsai YN, Cheng CC, Wang HW, 2016: c-Myc and viral cofactor Kaposin B co-operate to elicit angiogenesis through modulating miRNome traits of endothelial cells[J]. BMC Syst Biol, 10, 1-.
-
Chaudhary PM, Jasmin A, Eby MT, Hood L, 1999: Modulation of the NF-κB pathway by virally encoded death effector domains-containing proteins[J]. Oncogene, 18, 5738-5746. doi: 10.1038/sj.onc.1202976
-
Chen J, Ueda K, Sakakibara S, Okuno T, Parravicini C, Corbellino M, Yamanishi K, 2001: Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator[J]. Proc Natl Acad Sci USA, 98, 4119-4124. doi: 10.1073/pnas.051004198
-
Chen J, Ye F, Xie J, Kuhne K, Gao SJ, 2009: Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA[J]. Virology, 386, 290-302. doi: 10.1016/j.virol.2009.01.031
-
Chen HS, Wikramasinghe P, Showe L, Lieberman PM, 2012: Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency[J]. J Virol, 86, 9454-9464. doi: 10.1128/JVI.00787-12
-
Chen HS, Lu F, Lieberman PM, 2013: Epigenetic regulation of EBV and KSHV latency[J]. Curr Opin Virol, 3, 251-259. doi: 10.1016/j.coviro.2013.03.004
-
Cheng F, Weidner-Glunde M, Varjosalo M, Rainio EM, Lehtonen A, Schulz TF, Koskinen PJ, Taipale J, Ojala PM, 2009: KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA[J]. PLoS Pathog, 5, e1000324-. doi: 10.1371/journal.ppat.1000324
-
Chugh PE, Sin SH, Ozgur S, Henry DH, Menezes P, Griffith J, Eron JJ, Damania B, Dittmer DP, 2013: Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies[J]. PLoS Pathog, 9, e1003484-. doi: 10.1371/journal.ppat.1003484
-
Cianfrocca M, Cooley TP, Lee JY, Rudek MA, Scadden DT, Ratner L, Pluda JM, Figg WD, Krown SE, Dezube BJ, 2002: Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study[J]. J Clin Oncol, 20, 153-159.
-
Cook-Mozaffari P, Newton R, Beral V, Burkitt DP, 1998: The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic[J]. Br J Cancer, 78, 1521-1528. doi: 10.1038/bjc.1998.717
-
Corcoran JA, McCormick C, 2015: Viral activation of stress-regulated Rho-GTPase signaling pathway disrupts sites of mRNA degradation to influence cellular gene expression[J]. Small GTPases, 6, 178-185. doi: 10.1080/21541248.2015.1093068
-
Coscoy L, 2007: Immune evasion by Kaposi's sarcoma-associated herpesvirus[J]. Nat Rev Immunol, 7, 391-401. doi: 10.1038/nri2076
-
Cousins E, Nicholas J, 2013: Role of human herpesvirus 8 interleukin-6-activated gp130 signal transducer in primary effusion lymphoma cell growth and viability[J]. J Virol, 87, 10816-10827. doi: 10.1128/JVI.02047-13
-
Dai L, Qiao J, Nguyen D, Struckhoff AP, Doyle L, Bonstaff K, Valle LD, Parsons C, Toole BP, Renne R, Qin Z, 2016: Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus[J]. Oncotarget, 7, 10459-10471.
-
Davis DA, Rinderknecht AS, Zoeteweij JP, Aoki Y, Read-Connole EL, Tosato G, Blauvelt A, Yarchoan R, 2001: Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus[J]. Blood, 97, 3244-3250. doi: 10.1182/blood.V97.10.3244
-
Davis ZH, Verschueren E, Jang GM, Kleffman K, Johnson JR, Park J, Von Dollen J, Maher MC, Johnson T, Newton W, Jager S, Shales M, Horner J, Hernandez RD, Krogan NJ, Glaunsinger BA, 2015: Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes[J]. Mol Cell, 57, 349-360. doi: 10.1016/j.molcel.2014.11.026
-
De Leon Vazquez E, Kaye KM, 2011: The internal Kaposi's sarcoma-associated herpesvirus LANA regions exert a critical role on episome persistence[J]. J Virol, 85, 7622-7633. doi: 10.1128/JVI.00304-11
-
Deng H, Young A, Sun R, 2000: Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus[J]. J Gen Virol, 81, 3043-3048. doi: 10.1099/0022-1317-81-12-3043
-
Deng Z, Wang Z, Lieberman PM, 2012: Telomeres and viruses: common themes of genome maintenance[J]. Front Oncol, 2, 201-.
-
Dimaio TA, Lagunoff M, 2012: KSHV induction of angiogenic and lymphangiogenic phenotypes[J]. Front Microbiol, 3, 102-.
-
Dittmer DP, Damania B, 2016: Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy[J]. J Clin Invest, 126, 3165-3175. doi: 10.1172/JCI84418
-
Dittmer D, Lagunoff M, Renne R, Staskus KA, Haase A, Ganem D, 1998: A cluster of latently expressed genes in Kaposi's Sarcoma-associated herpesvirus[J]. J Virol, 72, 8309-8315.
-
Dollard SC, Nelson KE, Ness PM, Stambolis V, Kuehnert MJ, Pellett PE, Cannon MJ, 2005: Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort[J]. Transfusion, 45, 500-503. doi: 10.1111/trf.2005.45.issue-4
-
Dollard SC, Butler LM, Jones AM, Mermin JH, Chidzonga M, Chipato T, Shiboski CH, Brander C, Mosam A, Kiepiela P, Hladik W, Martin JN, 2010: Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt"[J]. Int J Cancer, 127, 2395-2401. doi: 10.1002/ijc.25235
-
Dorsett D, 2011: Cohesin: genomic insights into controlling gene transcription and development[J]. Curr Opin Genet Dev, 21, 199-206. doi: 10.1016/j.gde.2011.01.018
-
Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM, 2003: Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) epidemiology and pathogenesis[J]. Microbiol Mol Biol Rev, 67, 175-212. doi: 10.1128/MMBR.67.2.175-212.2003
-
Duan W, Wang S, Liu S, Wood C, 2001: Characterization of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF57 promoter[J]. Arch Virol, 146, 403-413. doi: 10.1007/s007050170185
-
Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, Marck EV, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K, Boshoff C, 1999: Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma[J]. Proc Natl Acad Sci USA, 96, 4546-4551. doi: 10.1073/pnas.96.8.4546
-
Ellison TJ, Izumiya Y, Izumiya C, Luciw PA, Kung HJ, 2009: A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus[J]. Virology, 387, 76-88. doi: 10.1016/j.virol.2009.02.016
-
Eltom MA, Mbulaiteye SM, Dada AJ, Whitby D, Biggar RJ, 2002: Transmission of human herpesvirus 8 by sexual activity among adults in Lagos, Nigeria[J]. AIDS, 16, 2473-2478. doi: 10.1097/00002030-200212060-00014
-
Fakhari FD, Dittmer DP, 2002: Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR[J]. J Virol, 76, 6213-6223. doi: 10.1128/JVI.76.12.6213-6223.2002
-
Fatahzadeh M, 2012: Kaposi sarcoma: review and medical management update[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 113, 2-16. doi: 10.1016/j.tripleo.2011.05.011
-
Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C, Collins M, 2003: KSHV vFLIP binds to IKK-γ to activate IKK[J]. J Cell Sci, 116, 3721-3728. doi: 10.1242/jcs.00691
-
Flore O, Raffi S, Ely S, O'Leary JJ, Hyjek EM, Cesarman E, 1998: Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus[J]. Nature, 394, 588-592. doi: 10.1038/29093
-
Ford PW, Bryan BA, Dyson OF, Weidner DA, Chintalgattu V, Akula SM, 2006: Raf/MEK/ERK signalling triggers reactivation of Kaposi's sarcoma-associated herpesvirus latency[J]. J Gen Virol, 87, 1139-1144. doi: 10.1099/vir.0.81628-0
-
Forte E, Raja AN, Shamulailatpam P, Manzano M, Schipma MJ, Casey JL, Gottwein E, 2015: MicroRNA-mediated transformation by the Kaposi's sarcoma-associated herpesvirus Kaposin locus[J]. J Virol, 89, 2333-2341. doi: 10.1128/JVI.03317-14
-
Fu B, Sun F, Li B, Yang L, Zeng Y, Sun X, Xu F, Rayner S, Guadalupe M, Gao SJ, Wang L, 2009: Seroprevalence of Kaposi's sarcoma-associated herpesvirus and risk factors in Xinjiang, China[J]. J Med Virol, 81, 1422-1431. doi: 10.1002/jmv.v81:8
-
Fujimuro M, Liu J, Zhu J, Yokosawa H, Hayward SD, 2005: Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen[J]. J Virol, 79, 10429-10441. doi: 10.1128/JVI.79.16.10429-10441.2005
-
Full F, Jungick D, Reuter N, Bogner E, Brulois K, Scholz B, Sturzl M, Myoung J, Jung JU, Stamminger T, Ensser A, 2014: Kaposi's sarcoma associated herpesvirus tegument protein ORF75 is essential for viral lytic replication and plays a critical role in the antagonization of ND10-Instituted intrinsic immunity[J]. PLoS Pathog, 10, e1003863-. doi: 10.1371/journal.ppat.1003863
-
Ganem D, : KSHV and Kaposi's Sarcoma: the end of the beginning?[J]. Cell, 91, 157-160. doi: 10.1016/S0092-8674(00)80398-0
-
Ganem D, 2010: KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine[J]. J Clin Invest, 120, 939-949. doi: 10.1172/JCI40567
-
Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS, 1996: KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma[J]. Nat Med, 2, 925-928. doi: 10.1038/nm0896-925
-
Garber AC, Shu MA, Hu J, Renne R, 2001: DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus[J]. J Virol, 75, 7882-7892. doi: 10.1128/JVI.75.17.7882-7892.2001
-
Giffin L, Damania B, 2014: KSHV: pathways to tumorigenesis and persistent infection[J]. Adv Virus Res, 88, 111-159. doi: 10.1016/B978-0-12-800098-4.00002-7
-
Gillen J, Li W, Liang Q, Avey D, Wu J, Wu F, Myoung J, Zhu F, 2015: A survey of the interactome of Kaposi's sarcoma-associated herpesvirus ORF45 revealed its binding to viral ORF33 and cellular USP7, resulting in stabilization of ORF33 that is required for production of progeny viruses[J]. J Virol, 89, 4918-4931. doi: 10.1128/JVI.02925-14
-
Godden-Kent D, Talbot SJ, Boshoff C, Chang Y, Moore P, Weiss RA, Mittnacht S, 1997: The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 To phosphorylate the retinoblastoma protein and histone H1[J]. J Virol, 71, 4193-4198.
-
Gottwein E, Cai X, Cullen BR, 2006: Expression and function of microRNAs encoded by Kaposi's sarcoma-associated herpesvirus[J]. Cold Spring Harb Symp Quant Biol, 71, 357-364. doi: 10.1101/sqb.2006.71.004
-
Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR, 2007: A viral microRNA functions as an orthologue of cellular miR-155[J]. Nature, 450, 1096-1099. doi: 10.1038/nature05992
-
Gottwein E, Corcoran DL, Mukherjee N, Skalsky RL, Hafner M, Nusbaum JD, Shamulailatpam P, Love CL, Dave SS, Tuschl T, Ohler U, Cullen BR, 2011: Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines[J]. Cell Host Microbe, 10, 515-526. doi: 10.1016/j.chom.2011.09.012
-
Gradoville L, Gerlach J, Grogan E, Shedd D, Nikiforow S, Metroka C, Miller G, 2000: Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line[J]. J Virol, 74, 6207-6212. doi: 10.1128/JVI.74.13.6207-6212.2000
-
Graham C, Matta H, Yang Y, Yi H, Suo Y, Tolani B, Chaudhary PM, 2013: Kaposi's sarcoma-associated herpesvirus oncoprotein K13 protects against B cell receptor-induced growth arrest and apoptosis through NF-kappaB activation[J]. J Virol, 87, 2242-2252. doi: 10.1128/JVI.01393-12
-
Gregory SM, West JA, Dillon PJ, Hilscher C, Dittmer DP, Damania B, 2009: Toll-like receptor signaling controls reactivation of KSHV from latency[J]. Proc Natl Acad Sci USA, 106, 11725-11730. doi: 10.1073/pnas.0905316106
-
Gregory SM, Davis BK, West JA, Taxman DJ, Matsuzawa S, Reed JC, Ting JP, Damania B, 2011: Discovery of a viral NLR homolog that inhibits the inflammasome[J]. Science, 331, 330-334. doi: 10.1126/science.1199478
-
Griffiths R, Whitehouse A, 2007: Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2[J]. J Virol, 81, 4021-4032. doi: 10.1128/JVI.02171-06
-
Grossmann C, Podgrabinska S, Skobe M, Ganem D, 2006: Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype[J]. J Virol, 80, 7179-7185. doi: 10.1128/JVI.01603-05
-
Grundhoff A, Sullivan CS, Ganem D, 2006: A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses[J]. RNA, 12, 733-750. doi: 10.1261/rna.2326106
-
Guasparri I, Keller SA, Cesarman E, 2004: KSHV vFLIP is essential for the survival of infected lymphoma cells[J]. J Exp Med, 199, 993-1003. doi: 10.1084/jem.20031467
-
Gunther T, Grundhoff A, 2010: The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes[J]. PLoS Pathog, 6, e1000935-. doi: 10.1371/journal.ppat.1000935
-
Haas DA, Bala K, Busche G, Weidner-Glunde M, Santag S, Kati S, Gramolelli S, Damas M, Dittrich-Breiholz O, Kracht M, Ruckert J, Varga Z, Keri G, Schulz TF, 2013: The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells[J]. PLoS Pathog, 9, e1003737-. doi: 10.1371/journal.ppat.1003737
-
Haddad L, El Hajj H, Abou-Merhi R, Kfoury Y, Mahieux R, El-Sabban M, Bazarbachi A, 2008: KSHV-transformed primary effusion lymphoma cells induce a VEGF-dependent angiogenesis and establish functional gap junctions with endothelial cells[J]. Leukemia, 22, 826-834. doi: 10.1038/sj.leu.2405081
-
Hahn AS, Kaufmann JK, Wies E, Naschberger E, Panteleev-Ivlev J, Schmidt K, Holzer A, Schmidt M, Chen J, Konig S, Ensser A, Myoung J, Brockmeyer NH, Sturzl M, Fleckenstein B, Neipel F, 2012: The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma-associated herpesvirus[J]. Nat Med, 18, 961-966. doi: 10.1038/nm.2805
-
Han Z, Swaminathan S, 2006: Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production[J]. J Virol, 80, 5251-5260. doi: 10.1128/JVI.02570-05
-
Haque M, Davis DA, Wang V, Widmer I, Yarchoan R, 2003: Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic Induction by hypoxia[J]. J Virol, 77, 6761-6768. doi: 10.1128/JVI.77.12.6761-6768.2003
-
Hensler HR, Tomaszewski MJ, Rappocciolo G, Rinaldo CR, Jenkins FJ, 2014: Human herpesvirus 8 glycoprotein B binds the entry receptor DC-SIGN[J]. Virus Res, 190, 97-103. doi: 10.1016/j.virusres.2014.07.003
-
Herold M, Bartkuhn M, Renkawitz R, 2012: CTCF: insights into insulator function during development[J]. Development, 139, 1045-1057. doi: 10.1242/dev.065268
-
Hladik W, Dollard SC, Mermin J, Fowlkes AL, Downing D, Amin MM, Banage F, Nzaro E, Kataaha P, Dondero TJ, Pellett PE, Lackritz EM, 2006: Transmission of human herpesvirus 8 by blood transfusion[J]. N Engl J Med, 355, 1331-1338. doi: 10.1056/NEJMoa055009
-
Hladik W, Pellett PE, Hancock J, Downing R, Gao H, Packel L, Mimbe D, Nzaro E, Mermin J, 2012: Association between transfusion with human herpesvirus 8 antibody-positive blood and subsequent mortality[J]. J Infect Dis, 206, 1497-1503. doi: 10.1093/infdis/jis543
-
Hu J, Renne R, 2005: Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin[J]. J Virol, 79, 2637-2642. doi: 10.1128/JVI.79.4.2637-2642.2005
-
Hu Z, Usherwood EJ, 2014: Immune escape of gamma-herpesviruses from adaptive immunity[J]. Rev Med Virol, 24, 365-378. doi: 10.1002/rmv.v24.6
-
Hu J, Yang Y, Turner PC, Jain V, McIntyre LM, Renne R, 2014: LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex[J]. PLoS Pathog, 10, e1004240-. doi: 10.1371/journal.ppat.1004240
-
Hu M, Wang C, Li W, Lu W, Bai Z, Qin D, Yan Q, Zhu J, Krueger BJ, Renne R, Gao SJ, Lu C, 2015: A KSHV microRNA directly targets G protein-coupled receptor kinase 2 to promote the migration and invasion of endothelial cells by inducing CXCR113 and activating AKT signaling[J]. PLoS Pathog, 11, e1005171-. doi: 10.1371/journal.ppat.1005171
-
Hunte R, Alonso P, Thomas R, Bazile CA, Ramos JC, van der Weyden L, Dominguez-Bendala J, Khan WN, Shembade N, 2018: CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-kappaB activation[J]. PLoS Pathog, 14, e1006968-. doi: 10.1371/journal.ppat.1006968
-
Iscovich J, Boffetta P, Winkelmann R, Brennan P, Azizi E, 1998: Classic Kaposi's sarcoma in Jews living in Israel[J]. AIDS, 12, 2067-2072. doi: 10.1097/00002030-199815000-00019
-
Ishido S, Wang C, Lee BS, Cohen GB, Jung JU, 2000: Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins[J]. J Virol, 74, 5300-5309. doi: 10.1128/JVI.74.11.5300-5309.2000
-
Izumiya Y, Lin SF, Ellison TJ, Levy AM, Mayeur GL, Izumiya C, Kung HJ, 2003: Cell cycle regulation by Kaposi's Sarcoma-associated herpesvirus K-bZIP: direct interaction with cyclin-CDK2 and induction of G1 growth arrest[J]. J Virol, 77, 9652-9661. doi: 10.1128/JVI.77.17.9652-9661.2003
-
Jackson BR, Boyne JR, Noerenberg M, Taylor A, Hautbergue GM, Walsh MJ, Wheat R, Blackbourn DJ, Wilson SA, Whitehouse A, 2011: An interaction between KSHV ORF57 and UIF provides mRNA-adaptor redundancy in herpesvirus intronless mRNA export[J]. PLoS Pathog, 7, e1002138-. doi: 10.1371/journal.ppat.1002138
-
Jarviluoma A, Koopal S, Rasanen S, Makela TP, Ojala PM, 2004: KSHV viral cyclin binds to p27KIP1 in primary effusion lymphomas[J]. Blood, 104, 3349-3354. doi: 10.1182/blood-2004-05-1798
-
Jenner RG, Alba MM, Boshoff C, Kellam P, 2001: Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays[J]. J Virol, 75, 891-902. doi: 10.1128/JVI.75.2.891-902.2001
-
Jha HC, Lu J, Verma SC, Banerjee S, Mehta D, Robertson ES, 2014: Kaposi's sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells[J]. MBio, 5, e02261-14.
-
Jones KD, Aoki Y, Chang Y, Moore PS, Yarchoan R, Tosato G, 1999: Involvement of Interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells[J]. Blood, 94, 2871-2879.
-
Jones T, Ye F, Bedolla R, Huang Y, Meng J, Qian L, Pan H, Zhou F, Moody R, Wagner B, Arar M, Gao SJ, 2012: Direct and efficient cellular transformation of primary rat mesenchymal precursor cells by KSHV[J]. J Clin Invest, 122, 1076-1081. doi: 10.1172/JCI58530
-
Jones T, Ramos da Silva S, Bedolla R, Ye F, Zhou F, Gao SJ, 2014: Viral cyclin promotes KSHV-induced cellular transformation and tumorigenesis by overriding contact inhibition[J]. Cell Cycle, 13, 845-858. doi: 10.4161/cc.27758
-
Jr JF, Kong WP, Hottiger MO, Nabel GJ, 1999: p53 inhibition by the LANA of KSHV protect against cell death[J]. Nature, 402, 889-894. doi: 10.1038/47266
-
Kakavand-Ghalehnoei R, Shoja Z, Najafi A, Mollahoseini MH, Shahmahmoodi S, Marashi SM, Nejati A, Jalilvand S, 2016: Prevalence of human herpesvirus-8 among HIV-infected patients, intravenous drug users and the general population in Iran[J]. Sex Health, 13, 295-298. doi: 10.1071/SH15192
-
Kaleeba JA, Berger EA, 2006: Kaposi's sarcoma-associated Herpesvirus fusion-entry receptor: cystine transporter xCT[J]. Science, 311, 1921-1924. doi: 10.1126/science.1120878
-
Kang H, Wiedmer A, Yuan Y, Robertson ES, Lieberman PM, 2011: Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation[J]. PLoS Pathog, 7, e1002140-. doi: 10.1371/journal.ppat.1002140
-
Kang JG, Majerciak V, Uldrick TS, Wang X, Kruhlak M, Yarchoan R, Zheng ZM, 2011a: Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation[J]. J Pathol, 225, 378-389. doi: 10.1002/path.2962
-
Kang JG, Pripuzova N, Majerciak V, Kruhlak M, Le SY, Zheng ZM, 2011b: Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression[J]. J Virol, 85, 2620-2630. doi: 10.1128/JVI.02144-10
-
Kaplan L, 2013: Human herpesvirus-8: Kaposi sarcoma, multicentric castleman disease, and primary effusion lymphoma[J]. Hematol Am Soc Hematol Educ Program, 2013, 103-108. doi: 10.1182/asheducation-2013.1.103
-
Kedes DH, Lagunoff M, Renne R, Ganem D, 1997: Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's Sarcoma-associated Herpesvirus[J]. J Clin Investig, 100, 2606-2610. doi: 10.1172/JCI119804
-
Kelley-Clarke B, De Leon-Vazquez E, Slain K, Barbera AJ, Kaye KM, 2009: Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence[J]. J Virol, 83, 4326-4337. doi: 10.1128/JVI.02395-08
-
Kieffer-Kwon P, Happel C, Uldrick TS, Ramalingam D, Ziegelbauer JM, 2015: KSHV microRNAs repress tropomyosin 1 and increase anchorage-independent growth and endothelial tube formation[J]. PLoS ONE, 10, e0135560-. doi: 10.1371/journal.pone.0135560
-
Kieshner JR, Lukac DM, Chang J, Ganem D, 2000: Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities[J]. J Virol, 74, 3586-3597. doi: 10.1128/JVI.74.8.3586-3597.2000
-
Kliche S, Nagel W, Kremmer E, Atzler C, Ege A, Knorr T, Koszinowski U, Kolanus W, Haas J, 2001: Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1[J]. Mol Cells, 7, 833-843. doi: 10.1016/S1097-2765(01)00227-1
-
Ko YC, Tsai WH, Wang PW, Wu IL, Lin SY, Chen YL, Chen JY, Lin SF, 2012: Suppressive regulation of KSHV RTA with O-GlcNAcylation[J]. J Biomed Sci, 19, 12-. doi: 10.1186/1423-0127-19-12
-
Koyano S, Mar EC, Stamey FR, Inoue N, 2003: Glycoproteins M and N of human herpesvirus 8 form a complex and inhibit cell fusion[J]. J Gen Virol, 84, 1485-1491. doi: 10.1099/vir.0.18941-0
-
Krishnan HH, Sharma-Walia N, Zeng L, Gao SJ, Chandran B, 2005: Envelope glycoprotein gB of Kaposi's sarcoma-associated herpesvirus is essential for egress from infected cells[J]. J Virol, 79, 10952-10967. doi: 10.1128/JVI.79.17.10952-10967.2005
-
Krithivas A, Fujimuro M, Weidner M, Young DB, Hayward SD, 2002: Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes[J]. J Virol, 76, 11596-11604. doi: 10.1128/JVI.76.22.11596-11604.2002
-
Krueger A, Baumann S, Krammer PH, Kirchhoff S, 2001: FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis[J]. Mol Cell Biol, 21, 8247-8254. doi: 10.1128/MCB.21.24.8247-8254.2001
-
Lagunoff M, Bechtel J, Venetsanakos E, Roy AM, Abbey N, Herndier B, McMahon M, Ganem D, 2002: De novo infection and serial transmission of Kaposi's Sarcoma-associated herpesvirus in cultured endothelial cells[J]. J Virol, 76, 2440-2448. doi: 10.1128/jvi.76.5.2440-2448.2002
-
Lai IY, Farrell PJ, Kellam P, 2011: X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma[J]. J Gen Virol, 92, 421-431. doi: 10.1099/vir.0.025494-0
-
Laman H, Coverley D, Krude T, Laskey R, Jones N, 2001: Viral cyclin-cyclin-dependent kinase 6 complexes initiate nuclear DNA replication[J]. Mol Cell Biol, 21, 624-635. doi: 10.1128/MCB.21.2.624-635.2001
-
Lan K, Kuppers DA, Verma SC, Robertson ES, 2004: Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency[J]. J Virol, 78, 6585-6594. doi: 10.1128/JVI.78.12.6585-6594.2004
-
Lan K, Kuppers DA, Robertson ES, 2005a: Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway[J]. J Virol, 79, 3468-3478. doi: 10.1128/JVI.79.6.3468-3478.2005
-
Lan K, Kuppers DA, Verma SC, Sharma N, Murakami M, Robertson ES, 2005b: Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency[J]. J Virol, 79, 7453-7465. doi: 10.1128/JVI.79.12.7453-7465.2005
-
Lan K, Murakami M, Choudhuri T, Kuppers DA, Robertson ES, 2006: Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency[J]. Virology, 351, 393-403. doi: 10.1016/j.virol.2006.03.047
-
Lavreys L, Chohan B, Ashley R, Richardson BA, Corey L, Mandaliya K, Ndinya-Achola JO, Kreiss JK, 2003: Human herpesvirus 8: seroprevalence and correlates in prostitutes in Mombasa, Kenya[J]. J Infect Dis, 187, 359-363. doi: 10.1086/jid.2003.187.issue-3
-
Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU, 2010: Immune evasion by Kaposi's sarcoma-associated herpesvirus[J]. Future Microbiol, 5, 1349-1365. doi: 10.2217/fmb.10.105
-
Lee HR, Brulois K, Wong L, Jung JU, 2012: Modulation of immune system by Kaposi's Sarcoma-associated herpesvirus: lessons from viral evasion strategies[J]. Front Microbiol, 3, 44-.
-
Lee HR, Choi UY, Hwang SW, Kim S, Jung JU, 2016a: Viral inhibition of PRR-mediated innate immune response: learning from KSHV evasion strategies[J]. Mol Cells, 39, 777-782. doi: 10.14348/molcells.2016.0232
-
Lee HR, Mitra J, Lee S, Gao SJ, Oh TK, Kim MH, Ha T, Jung JU, 2016b: Kaposi's Sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) perturbs the G1-S cell cycle progression via deregulation of the cyclin D1 gene[J]. J Virol, 90, 1139-1143. doi: 10.1128/JVI.01897-15
-
Lee MS, Yuan H, Jeon H, Zhu Y, Yoo S, Shi S, Krueger B, Renne R, Lu C, Jung JU, Gao SJ, 2016c: Human mesenchymal stem cells of diverse origins support persistent infection with Kaposi's sarcoma-associated herpesvirus and manifest distinct angiogenic, invasive, and transforming phenotypes[J]. MBio, , e02109-e02115.
-
Lei X, Bai Z, Ye F, Xie J, Kim CG, Huang Y, Gao SJ, 2010: Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA[J]. Nat Cell Biol, 12, 193-199. doi: 10.1038/ncb2019
-
Lennette ET, Blackbourn DJ, Levy JA, 1996: Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients[J]. Lancet, 348, 858-861. doi: 10.1016/S0140-6736(96)03240-0
-
Li J, Huang Y, Cockerell CJ, Friedman-Kien AE, 1996: Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's Sarcoma lesions by in situ hybridization[J]. Am J Pathol, 148, 1741-1748.
-
Li M, Lee H, Yoon DW, Albrecht JC, Fleckenstein B, Neipel F, Jung JU, 1997: Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin[J]. J Virol, 71, 1984-1991.
-
Li FY, Jeffrey PD, Yu JW, Shi Y, 2006: Crystal structure of a viral FLIP: insights into FLIP-mediated inhibition of death receptor signaling[J]. J Biol Chem, 281, 2960-2968. doi: 10.1074/jbc.M511074200
-
Li Q, Zhou F, Ye F, Gao SJ, 2008: Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program[J]. Virology, 379, 234-244. doi: 10.1016/j.virol.2008.06.043
-
Li W, Avey D, Fu B, Wu JJ, Ma S, Liu X, Zhu F, 2016a: Kaposi's sarcoma-associated herpesvirus inhibitor of cGAS (KicGAS), encoded by ORF52, is an abundant tegument protein and is required for production of infectious progeny viruses[J]. J Virol, 90, 5329-5342. doi: 10.1128/JVI.02675-15
-
Li W, Jia XM, Shen C, Zhang M, Xu J, Shang Y, Zhu K, Hu M, Yan Q, Qin D, Lee M, Zhu J, Lu H, Krueger BJ, Renne R, Gao SJ, Lu C, 2016b: A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR164/AKT pathway[J]. Oncotarget, 7, 32286-32305.
-
Li W, Yan Q, Ding X, Shen C, Hu M, Zhu Y, Qin D, Lu H, Krueger BJ, Renne R, Gao SJ, Lu C, 2016c: The SH3BGR/STAT3 pathway regulates cell migration and angiogenesis induced by a gammaherpesvirus MicroRNA[J]. PLoS Pathog, 12, e1005605-. doi: 10.1371/journal.ppat.1005605
-
Li W, Hu M, Wang C, Lu H, Chen F, Xu J, Shang Y, Wang F, Qin J, Yan Q, Krueger BJ, Renne R, Gao SJ, Lu C, 2017: A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling[J]. Oncogene, 36, 5407-5420. doi: 10.1038/onc.2017.139
-
Li Y, Zhong C, Liu D, Yu W, Chen W, Wang Y, Shi S, Yuan Y, 2018: Evidence for Kaposi sarcoma originating from Mesenchymal stem cell through KSHV-induced Mesenchymal-to-endothelial transition[J]. Cancer Res, 78, 230-245.
-
Liang D, Gao Y, Lin X, He Z, Zhao Q, Deng Q, Lan K, 2011: A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKK epsilon[J]. Cell Res, 21, 793-806. doi: 10.1038/cr.2011.5
-
Liao W, Tang Y, Lin SF, Kung HJ, Giam CZ, 2003: K-bZIP of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-Mediated transactivation[J]. J Virol, 77, 3809-3815. doi: 10.1128/JVI.77.6.3809-3815.2003
-
Lim C, Sohn H, Gwack Y, Choe J, 2000: Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity[J]. J Gen Virol, 81, 2645-2652. doi: 10.1099/0022-1317-81-11-2645
-
Lim C, Sohn H, Lee D, Gwack Y, Choe J, 2002: Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome[J]. J Virol, 76, 10320-10331. doi: 10.1128/JVI.76.20.10320-10331.2002
-
Lin C, Li H, Wang Y, Zhu FX, Kudchodkar S, Yuan Y, 2003: Kaposi's Sarcoma-associated herpesvirus lytic origin (ori-Lyt)-dependent DNA replication: identification of the ori-Lyt and association of K8 bZip protein with the origin[J]. J Virol, 77, 5578-5588. doi: 10.1128/JVI.77.10.5578-5588.2003
-
Lin X, Liang D, He Z, Deng Q, Robertson E, Lan K, 2011: miR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA[J]. PLoS ONE, 6, e16224-. doi: 10.1371/journal.pone.0016224
-
Lin X, Li X, Liang D, Lan K, 2012: MicroRNAs and unusual small RNAs discovered in Kaposi's sarcoma-associated herpesvirus virions[J]. J Virol, 86, 12717-12730. doi: 10.1128/JVI.01473-12
-
Lisco A, Barbierato M, Fiore JR, Gasperini P, Favia A, Volpe A, Chironna M, Pastore G, Chieco-Bianchi L, Calabro ML, 2006: Pregnancy and human herpesvirus 8 reactivation in human immunodeficiency virus type 1-infected women[J]. J Clin Microbiol, 44, 3863-3871. doi: 10.1128/JCM.00791-06
-
Liu Z, Fang Q, Zhou S, Minhas V, Wood C, He N, Zhang T, 2017: Seroprevalence of Kaposi's sarcoma-associated herpesvirus among HIV-infected Uygurs in Xinjiang, China[J]. J Med Virol, 89, 1629-1635. doi: 10.1002/jmv.v89.9
-
Liu D, Wang Y, Yuan Y, 2018: Kaposi's sarcoma-associated herpesvirus K8 is an RNA binding protein that regulates viral DNA replication in coordination with a noncoding RN[J]. J Virol, 92, e02177-17.
-
Lock MJ, Thorley N, Teo J, Emery VC, 2002: Azidodeoxythymidine and didehydrodeoxythymidine as inhibitors and substrates of the human herpesvirus 8 thymidine kinase[J]. J Antimicrob Chemother, 49, 359-366. doi: 10.1093/jac/49.2.359
-
Lu F, Zhou J, Wiedmer A, Madden K, Yuan Y, Lieberman PM, 2003: Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency[J]. J Virol, 77, 11425-11435. doi: 10.1128/JVI.77.21.11425-11435.2003
-
Lu F, Day L, Gao SJ, Lieberman PM, 2006: Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription[J]. J Virol, 80, 5273-5282. doi: 10.1128/JVI.02541-05
-
Lu CC, Li Z, Chu CY, Feng J, Feng J, Sun R, Rana TM, 2010: MicroRNAs encoded by Kaposi's sarcoma-associated herpesvirus regulate viral life cycle[J]. EMBO Rep, 11, 784-790. doi: 10.1038/embor.2010.132
-
Lukac DM, Kirshner JR, Ganem D, 1999a: Transcriptional activation by the product of open reading frame 50 of Kaposi's Sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells[J]. J Virol, 73, 9348-9361.
-
Lukac DM, Kirshner JR, Ganem D, 1999b: Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus Is required for lytic viral reactivation in B cells[J]. J Virol, 73, 9348-9361.
-
Lukac DM, Garibyan L, Kirshner JR, Palmeri D, Ganem D, 2001: DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters[J]. J Virol, 75, 6786-6799. doi: 10.1128/JVI.75.15.6786-6799.2001
-
Majerciak V, Zheng ZM, 2009: Kaposi's sarcoma-associated herpesvirus ORF57 in viral RNA processing[J]. Front Biosci, 14, 1516-1528.
-
Majerciak V, Zheng ZM, 2015: KSHV ORF57, a protein of many faces[J]. Viruses, 7, 604-633. doi: 10.3390/v7020604
-
Majerciak V, Zheng ZM, 2016: Alternative RNA splicing of KSHV ORF57 produces two different RNA isoforms[J]. Virology, 488, 81-87. doi: 10.1016/j.virol.2015.10.031
-
Majerciak V, Yamanegi K, Nie SH, Zheng ZM, 2006a: Structural and functional analyses of Kaposi sarcoma-associated herpesvirus ORF57 nuclear localization signals in living cells[J]. J Biol Chem, 281, 28365-28378. doi: 10.1074/jbc.M603095200
-
Majerciak V, Yamanegi K, Zheng ZM, 2006b: Gene structure and expression of Kaposi's sarcoma-associated herpesvirus ORF56, ORF57, ORF58, and ORF59[J]. J Virol, 80, 11968-11981. doi: 10.1128/JVI.01394-06
-
Majerciak V, Pripuzova N, McCoy JP, Gao SJ, Zheng ZM, 2007: Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8[J]. 1 and the production of infectious virus. J Virol, 81, 1062-1071.
-
Majerciak V, Yamanegi K, Allemand E, Kruhlak M, Krainer AR, Zheng ZM, 2008: Kaposi's sarcoma-associated herpesvirus ORF57 functions as a viral splicing factor and promotes expression of intron-containing viral lytic genes in spliceosome-mediated RNA splicing[J]. J Virol, 82, 2792-2801. doi: 10.1128/JVI.01856-07
-
Majerciak V, Uranishi H, Kruhlak M, Pilkington GR, Massimelli MJ, Bear J, Pavlakis GN, Felber BK, Zheng ZM, 2011: Kaposi's sarcoma-associated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59[J]. J Virol, 85, 1528-1540. doi: 10.1128/JVI.01709-10
-
Majerciak V, Ni T, Yang W, Meng B, Zhu J, Zheng ZM, 2013: A viral genome landscape of RNA polyadenylation from KSHV latent to lytic infection[J]. PLoS Pathog, 9, e1003749-. doi: 10.1371/journal.ppat.1003749
-
Majerciak V, Lu M, Li X, Zheng ZM, 2014: Attenuation of the suppressive activity of cellular splicing factor SRSF3 by Kaposi sarcoma-associated herpesvirus ORF57 protein is required for RNA splicing[J]. RNA, 20, 1747-1758. doi: 10.1261/rna.045500.114
-
Majerciak V, Pripuzova N, Chan C, Temkin N, Specht SI, Zheng ZM, 2015: Stability of structured Kaposi's sarcoma-associated herpesvirus ORF57 protein is regulated by protein phosphorylation and homodimerization[J]. J Virol, 89, 3256-3274. doi: 10.1128/JVI.03721-14
-
Malik P, Blackbourn DJ, Clements JB, 2004: The evolutionarily conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF protein and acts as an RNA export factor[J]. J Biol Chem, 279, 33001-33011. doi: 10.1074/jbc.M313008200
-
Malope BI, MacPhail P, Mbisa G, MacPhail C, Stein L, Ratshikhopha EM, Ndhlovu L, Sitas F, Whitby D, 2008: No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population[J]. AIDS, 22, 519-526. doi: 10.1097/QAD.0b013e3282f46582
-
Mantina H, Kankasa C, Klaskala W, Brayfield B, Campbell J, Du Q, Bhat G, Kasolo F, Mitchell C, Wood C, 2001: Vertical transmission of Kaposi's sarcoma-associated herpesvirus[J]. Int J Cancer, 94, 749-752. doi: 10.1002/(ISSN)1097-0215
-
Martin JN, Ganem D, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH, 1998: Sexual transmission and the natural history of human herpesvirus 8 infection[J]. N Engl J Med, 338, 948-954. doi: 10.1056/NEJM199804023381403
-
Martinez FP, Tang Q, 2012: Leucine zipper domain is required for Kaposi sarcoma-associated herpesvirus (KSHV) K-bZIP protein to interact with histone deacetylase and is important for KSHV replication[J]. J Biol Chem, 287, 15622-15634. doi: 10.1074/jbc.M111.315861
-
Massimelli MJ, Kang JG, Majerciak V, Le SY, Liewehr DJ, Steinberg SM, Zheng ZM, 2011: Stability of a long noncoding viral RNA depends on a 9-nt core element at the RNA 5′ end to interact with viral ORF57 and cellular PABPC1[J]. Int J Biol Sci, 7, 1145-1160. doi: 10.7150/ijbs.7.1145
-
Massimelli MJ, Majerciak V, Kruhlak M, Zheng ZM, 2013: Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA[J]. J Virol, 87, 243-256. doi: 10.1128/JVI.01693-12
-
Massimelli MJ, Majerciak V, Kang JG, Liewehr DJ, Steinberg SM, Zheng ZM, 2015: Multiple regions of Kaposi's sarcoma-associated herpesvirus ORF59 RNA are required for its expression mediated by viral ORF57 and cellular RBM15[J]. Viruses, 7, 496-510. doi: 10.3390/v7020496
-
Matta H, Sun Q, Moses G, Chaudhary PM, 2003: Molecular genetic analysis of human herpes virus 8-encoded viral FLICE inhibitory protein-induced NF-kappaB activation[J]. J Biol Chem, 278, 52406-52411. doi: 10.1074/jbc.M307308200
-
Matta H, Mazzacurati L, Schamus S, Yang T, Sun Q, Chaudhary PM, 2007: Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation[J]. J Biol Chem, 282, 24858-24865. doi: 10.1074/jbc.M700118200
-
Matta H, Gopalakrishnan R, Graham C, Tolani B, Khanna A, Yi H, Suo Y, Chaudhary PM, 2012: Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-kappaB pathway independent of TRAF6, TAK1 and LUBAC[J]. PLoS ONE, 7, e36601-. doi: 10.1371/journal.pone.0036601
-
McAllister SC, Hansen SG, Ruhl RA, Raggo CM, DeFilippis VR, Greenspan D, Früh K, Moses AV, 2004: Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity inKSHV-infected endothelial cells[J]. Blood, 103, 3465-3473. doi: 10.1182/blood-2003-08-2781
-
McCormick C, Ganem D, 2005: The Kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs[J]. Science, 307, 739-741. doi: 10.1126/science.1105779
-
Meade-Tollin LC, Way D, Witte MH, 1999: Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells[J]. Acta Histochem, 101, 305-316. doi: 10.1016/S0065-1281(99)80031-2
-
Melbye M, Cook PM, Hjalgrim H, Begtrup K, Simpson GR, Biggar RJ, Ebbesen P, Schulz TF, 1998: Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996[J]. Int J Cancer, 77, 543-548. doi: 10.1002/(ISSN)1097-0215
-
Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov VM, Grossberg S, Chang Y, 1997: Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells[J]. J Virol, 71, 314-324.
-
Miller G, El-Guindy A, Countryman J, Ye J, Gradoville L, 2007: Lytic cycle switches of oncogenic human gammaherpesviruses 1[J]. Adv Cancer Res, 97, 81-109. doi: 10.1016/S0065-230X(06)97004-3
-
Minhas V, Wood C, 2014: Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus[J]. Viruses, 6, 4178-4194. doi: 10.3390/v6114178
-
Molden J, Chang Y, You Y, Moore PS, Goldsmith MA, 1997: A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit[J]. J Biol Chem, 272, 19625-19631. doi: 10.1074/jbc.272.31.19625
-
Moldovan GL, Pfander B, Jentsch S, 2007: PCNA, the maestro of the replication fork[J]. Cell, 129, 665-679. doi: 10.1016/j.cell.2007.05.003
-
Mollica L, Bessa LM, Hanoulle X, Jensen MR, Blackledge M, Schneider R, 2016: binding mechanisms of intrinsically disordered proteins: theory, simulation, and experiment[J]. Front Mol Biosci, 3, 52-.
-
Moody R, Zhu Y, Huang Y, Cui X, Jones T, Bedolla R, Lei X, Bai Z, Gao SJ, 2013: KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways[J]. PLoS Pathog, 9, e1003857-. doi: 10.1371/journal.ppat.1003857
-
Moore PS, Chang Y, : Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?[J]. Annu Rev Microbiol, 57, 609-639. doi: 10.1146/annurev.micro.57.030502.090824
-
Muralidhar S, Pumfery AM, Hassani M, Reza Sadaie M, Azumi N, Kishishita M, Brady JN, Doniger J, Medveczky P, Rosenthal LJ, 1998: Identification of Kaposin (open reading frame K12) as a human Herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene[J]. J Virol, 72, 4980-4988.
-
Myoung J, Ganem D, 2011a: Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction[J]. J Virol Methods, 174, 12-21. doi: 10.1016/j.jviromet.2011.03.012
-
Myoung J, Ganem D, 2011b: Infection of primary human tonsillar lymphoid cells by KSHV reveals frequent but abortive infection of T cells[J]. Virology, 413, 1-11. doi: 10.1016/j.virol.2010.12.036
-
Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O, 2009: Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells[J]. Cell Host Microbe, 5, 376-385. doi: 10.1016/j.chom.2009.03.003
-
Nakamura H, Lu M, Gwack Y, Souvlis J, Zeichner SL, Jung JU, 2003: Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator[J]. J Virol, 77, 4205-4220. doi: 10.1128/JVI.77.7.4205-4220.2003
-
Naranatt PP, Akula SM, Chandran B, 2002: Characterization of gamma2-human herpesvirus-8 glycoproteins gH and gL[J]. Arch Virol, 147, 1349-1370. doi: 10.1007/s00705-002-0813-7
-
Neipel F, Albrecht JC, Fleckenstein B, 1997: Cell-homologous genes in the Kaposi's sarcoma-associated Rhadinovirus Human Herpesvirus 8: determinants of its pathogenicity?[J]. J Virol, 71, 4187-4192.
-
Nekorchuk M, Han Z, Hsieh TT, Swaminathan S, 2007: Kaposi's sarcoma-associated herpesvirus ORF57 protein enhances mRNA accumulation independently of effects on nuclear RNA export[J]. J Virol, 81, 9990-9998. doi: 10.1128/JVI.00896-07
-
O'Byrne KJ, Dalgleish AG, Browning MJ, Steward WP, Harris AL, 2000: The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease[J]. Eur J Cancer, 36, 151-169. doi: 10.1016/S0959-8049(99)00241-5
-
Ohlsson R, Renkawitz R, Labanenkov V, 2001: CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease[J]. Trends Genet, 17, 520-527. doi: 10.1016/S0168-9525(01)02366-6
-
Ohsaki E, Ueda K, 2012: Kaposi's sarcoma-associated herpesvirus genome replication, partitioning, and maintenance in latency[J]. Front Microbiol, 3, 7-.
-
Ohsaki E, Ueda K, Sakakibara S, Do E, Yada K, Yamanishi K, 2004: Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency[J]. J Virol, 78, 9936-9946. doi: 10.1128/JVI.78.18.9936-9946.2004
-
Okroj M, Tedeschi R, Mancuso R, Brambilla L, Tourlaki A, Dillner J, Blom AM, 2011: Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters[J]. Vaccine, 29, 1129-1134. doi: 10.1016/j.vaccine.2010.11.070
-
Orenstein JM, 2008: Ultrastructure of Kaposi Sarcoma[J]. Ultrastruct Pathol, 32, 211-220. doi: 10.1080/01913120802343871
-
Ottinger M, Christalla T, Nathan K, Brinkmann MM, Viejo-Borbolla A, Schulz TF, 2006: Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest[J]. J Virol, 80, 10772-10786. doi: 10.1128/JVI.00804-06
-
Patel V, Dahlroth SL, Rajakannan V, Ho HT, Cornvik T, Nordlund P, 2015: Structure of the C-terminal domain of the multifunctional ICP27 protein from herpes simplex virus 1[J]. J Virol, 89, 8828-8839. doi: 10.1128/JVI.00441-15
-
Paul AG, Chandran B, Sharma-Walia N, 2013: Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies[J]. Transl Res, 162, 77-92. doi: 10.1016/j.trsl.2013.03.004
-
Pearce M, Matsumura S, Wilson AC, 2005: Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter[J]. J Virol, 79, 14457-14464. doi: 10.1128/JVI.79.22.14457-14464.2005
-
Persson LM, Wilson AC, 2010: Wide-scale use of Notch signaling factor CSL/RBP-Jkappa in RTA-mediated activation of Kaposi's sarcoma-associated herpesvirus lytic genes[J]. J Virol, 84, 1334-1347. doi: 10.1128/JVI.01301-09
-
Pertel PE, 2002: Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion[J]. J Virol, 76, 4390-4400. doi: 10.1128/JVI.76.9.4390-4400.2002
-
Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grässer FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T, 2005: Identification of microRNAs of the herpesvirus family[J]. Nat Methods, 2, 269-276. doi: 10.1038/nmeth746
-
Picchio GR, Sabbe RE, Gulizia RJ, Mcgrath M, Herndier BG, Moiser DE, 1997: The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID Mice but fails to transmit virus to a human peripheral blood mononuclear cell graft[J]. J Virol Methods, 238, 22-29.
-
Pilkington GR, Majerciak V, Bear J, Uranishi H, Zheng ZM, Felber BK, 2012: Kaposi's sarcoma-associated herpesvirus ORF57 is not a bona fide export factor[J]. J Virol, 86, 13089-13094. doi: 10.1128/JVI.00606-12
-
Purushothaman P, McDowell ME, McGuinness J, Salas R, Rumjahn SM, Verma SC, 2012: Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIbeta for latent DNA replication of the terminal repeats[J]. J Virol, 86, 9983-9994. doi: 10.1128/JVI.00839-12
-
Purushothaman P, Thakker S, Verma SC, 2015: Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells[J]. J Virol, 89, 3093-3111. doi: 10.1128/JVI.02507-14
-
Purushothaman P, Uppal T, Sarkar R, Verma SC, 2016: KSHV-mediated angiogenesis in tumor progression[J]. Viruses, 8, E198-. doi: 10.3390/v8070198
-
Qin J, Li W, Gao SJ, Lu C, 2017: KSHV microRNAs: tricks of the devil[J]. Trends Microbiol, 25, 648-661. doi: 10.1016/j.tim.2017.02.002
-
Quinlivan EB, Zhang C, Stewart PW, Komoltri C, Davis MG, Wehbie RS, 2002: Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not[J]. J Infect Dis, 185, 1736-1744. doi: 10.1086/jid.2002.185.issue-12
-
Radkov SA, Kellam R, Boshoff C, 2000: The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells[J]. Nat Med, 6, 1121-1127. doi: 10.1038/80459
-
Radu O, Pantanowitz L, 2013: Kaposi Sarcoma[J]. Arch Pathol Lab Med, 137, 289-294. doi: 10.5858/arpa.2012-0101-RS
-
Ramalingam D, Happel C, Ziegelbauer JM, 2015: Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis[J]. J Virol, 89, 4249-4261. doi: 10.1128/JVI.03687-14
-
Rappocciolo G, Jenkins FJ, Hensler HR, Piazza P, Jais M, Borowski L, Watkins SC, Rinaldo CR, 2006: DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages[J]. J Immunol, 176, 1741-1749. doi: 10.4049/jimmunol.176.3.1741
-
Renne R, Lagunoff M, Zhong W, Ganem D, 1996a: The size and conformation of Kaposi's Sarcoma-associated Herpesvirus (Human Herpesvirus 8) DNA in infected cells and virions[J]. J Virol, 70, 8151-8154.
-
Renne R, Zhong W, Herndier B, Mcgrath M, Abbey N, Kedes D, Ganem D, 1996b: Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture[J]. Nat Med, 2, 342-346. doi: 10.1038/nm0396-342
-
Renne R, Dittmer D, Kedes D, Schmidt K, Desrosiers RC, Luciw PA, Ganem D, 2004: Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SIV-positive and SIV-negative rhesus macaques[J]. J Med Primatol, 33, 1-9. doi: 10.1046/j.1600-0684.2003.00043.x
-
Revilla-López J, Mendoza-Fabián R, Anampa-Guzmán A, Rosales-Zúñiga J, Chalco-Huamán J, 2015: Sarcoma de Kaposi endemico en un paciente VIH negativo[J]. Rev Peru Med Exp Salud Publica, 32, 808-812. doi: 10.17843/rpmesp.2015.324.1776
-
Rivas C, Thlick AE, Parravicini C, Moore PS, Chang Y, 2001: Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53[J]. J Virol, 75, 429-438. doi: 10.1128/JVI.75.1.429-438.2001
-
Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore P, 1996: Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)[J]. Proc Natl Acad Sci USA, 93, 14862-14867. doi: 10.1073/pnas.93.25.14862
-
Sadagopan S, Sharma-Walia N, Veettil MV, Bottero V, Levine R, Vart RJ, Chandran B, 2009: Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis[J]. J Virol, 83, 3342-3364. doi: 10.1128/JVI.02052-08
-
Sadler R, Wu L, Forghani B, Renne R, Zhong W, Herndier B, Ganem D, 1999: A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus[J]. J Virol, 73, 5722-5730.
-
Sakakibara S, Tosato G, 2009: Regulation of angiogenesis in malignancies associated with Epstein-Barr virus and Kaposi's sarcoma-associated herpes virus[J]. Future Microbiol, 4, 903-917. doi: 10.2217/fmb.09.49
-
Sarek G, Jarviluoma A, Ojala PM, 2006: KSHVviral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas[J]. Blood, 107, 725-732. doi: 10.1182/blood-2005-06-2534
-
Sarek G, Jarviluoma A, Moore HM, Tojkander S, Vartia S, Biberfeld P, Laiho M, Ojala PM, 2010: Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency[J]. PLoS Pathog, 6, e1000818-. doi: 10.1371/journal.ppat.1000818
-
Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS, 1999: Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1)[J]. J Virol, 72, 1005-1012.
-
Sathish N, Wang X, Yuan Y, 2012: Tegument Proteins of Kaposi's sarcoma-associated herpesvirus and related gamma-herpesviruses[J]. Front Microbiol, 3, 98-.
-
Saveliev AK, Zhu FX, Yuan Y, 2002: Transcription mapping and expression patterns of genes in the major immediate-early region of Kaposi's sarcoma-associated herpesvirus[J]. Virology, 299, 301-314. doi: 10.1006/viro.2002.1561
-
Schaefke B, Sun W, Li YS, Fang L, Chen W, 2018: The evolution of posttranscriptional regulation[J]. Wiley Interdiscip Rev RNA, 9, e1485-. doi: 10.1002/wrna.2018.9.issue-5
-
Shamay M, Liu J, Li R, Liao G, Shen L, Greenway M, Hu S, Zhu J, Xie Z, Ambinder RF, Qian J, Zhu H, Hayward SD, 2012: A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening[J]. J Virol, 86, 5179-5191. doi: 10.1128/JVI.00169-12
-
Sharma NR, Majerciak V, Kruhlak MJ, Zheng ZM, 2017: KSHV inhibits stress granule formation by viral ORF57 blocking PKR activation[J]. PLoS Pathog, 13, e1006677-. doi: 10.1371/journal.ppat.1006677
-
Sharma-Walia N, Paul AG, Bottero V, Sadagopan S, Veettil MV, Kerur N, Chandran B, 2010: Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion[J]. PLoS Pathog, 6, e1000777-. doi: 10.1371/journal.ppat.1000777
-
Sharp TV, Wang HW, Koumi A, Hollyman D, Endo Y, Ye H, Du MQ, Boshoff C, 2002: K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function[J]. J Virol, 76, 802-816. doi: 10.1128/JVI.76.2.802-816.2002
-
Shin YC, Nakamura H, Liang X, Feng P, Chang H, Kowalik TF, Jung JU, 2006: Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1[J]. J Virol, 80, 2257-2266. doi: 10.1128/JVI.80.5.2257-2266.2006
-
Shin HJ, DeCotiis J, Giron M, Palmeri D, Lukac DM, 2014: Histone deacetylase classes Ⅰ and Ⅱ regulate Kaposi's sarcoma-associated herpesvirus reactivation[J]. J Virol, 88, 1281-1292. doi: 10.1128/JVI.02665-13
-
Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao S-J, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IVD, Weiss RA, Moore PS, 1996: Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen[J]. Lancet, 348, 1133-1138. doi: 10.1016/S0140-6736(96)07560-5
-
Singh VV, Dutta D, Ansari MA, Dutta S, Chandran B, 2014: Kaposi's sarcoma-associated herpesvirus induces the ATM and H2AX DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment[J]. J Virol, 88, 2821-2834. doi: 10.1128/JVI.03126-13
-
Skalsky RL, Hu J, Renne R, 2007: Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance[J]. J Virol, 81, 9825-9837. doi: 10.1128/JVI.00842-07
-
Smith NA, Sabin CA, Gopal R, Bourboulia D, Labbet W, Boshoff C, Barlow D, Band B, Peters BS, de Ruiter A, Brown DWG, Weiss RA, Best JM, Whitby D, 1999: Serologic evidence of Human Herpesvirus 8 transmission by homosexual but not heterosexual sex[J]. J Infect Dis, 180, 600-606. doi: 10.1086/jid.1999.180.issue-3
-
Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem P, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F, 1995: Kaposi's Sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease[J]. Blood, 86, 1276-1280.
-
Speck SH, Ganem D, 2010: Viral latency and its regulation: lessons from the gammaherpesviruses[J]. Cell Host Microbe, 8, 100-115. doi: 10.1016/j.chom.2010.06.014
-
Spiller OB, Robinson M, O'Donnell E, Milligan S, Morgan BP, Davison AJ, Blackbourn DJ, 2003: Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein[J]. J Virol, 77, 592-599. doi: 10.1128/JVI.77.1.592-599.2003
-
Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, Haase AT, 1997: Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells[J]. J Virol, 71, 715-719.
-
Stedman W, Deng Z, Lu F, Lieberman PM, 2004: ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin[J]. J Virol, 78, 12566-12575. doi: 10.1128/JVI.78.22.12566-12575.2004
-
Sturzl M, Blasig C, Schreier A, Neipel F, Hohenadl C, Cornali E, Ascherl G, Esser S, Brockmeyer NH, Ekman M, Kaaya EE, Tschachler E, Biberfeld P, 1997: Expression of HHV-8 latency-associated T0[J]. 7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's Sarcoma. Int J Cancer, 72, 68-71.
-
Sturzl M, Hohenadl C, Zietz C, Castanos-Velez E, Wunderlich A, Ascherl G, Biberfeld P, Monini P, Browning PJ, Ensoli B, 1999: Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells[J]. J Natl Cancer Inst, 91, 1725-1733. doi: 10.1093/jnci/91.20.1725
-
Sullivan CS, 2007: High conservation of Kaposi sarcoma-associated herpesvirus microRNAs implies important function[J]. J Infect Dis, 195, 618-620. doi: 10.1086/522471
-
Sun R, Lin S, Staskus KA, Gradoville L, Grogan E, Haase A, Miller G, 1999: Kinetics of Kaposi's Sarcoma-associated herpesvirus gene expression[J]. J Virol, 73, 2232-2242.
-
Sun Q, Tsurimoto T, Juillard F, Li L, Li SJ, De León Vázquez E, Chen S, Kaye K, 2014a: Kaposi's sarcoma-associated herpesvirus LANA recruits the DNA polymerase clamp loader to mediate efficient replication and virus persistence[J]. Proc Natl Acad Sci USA, 111, 11816-11821. doi: 10.1073/pnas.1404219111
-
Sun R, Liang D, Gao Y, Lan K, 2014b: Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency[J]. J Virol, 88, 7331-7344. doi: 10.1128/JVI.00596-14
-
Sun Z, Jha HC, Robertson ES, 2015: Bub1 in complex with LANA recruits PCNA to regulate kaposi's sarcoma-associated herpesvirus latent replication and DNA translesion synthesis[J]. J Virol, 89, 10206-10218. doi: 10.1128/JVI.01524-15
-
Tan B, Gao SJ, 2018: RNA epitranscriptomics: regulation of infection of RNA and DNA viruses by N(6) -methyladenosine (m(6) A)[J]. Rev Med Virol, 28, e1983-. doi: 10.1002/rmv.v28.4
-
Tan B, Liu H, Zhang S, da Silva SR, Zhang L, Meng J, Cui X, Yuan H, Sorel O, Zhang S-W, Huang Y, Gao SJ, 2017: Viral and cellular N6-methyladenosine and N6, 2′-O-dimethyladenosine epitranscriptomes in the KSHV life cycle[J]. Nat Microbiol, 3, 108-120.
-
Tang S, Zheng ZM, 2002: Kaposi's sarcoma-associated herpesvirus K8 exon 3 contains three 5′-splice sites and harbors a K8.1 transcription start site[J]. J Biol Chem, 277, 14547-14556. doi: 10.1074/jbc.M111308200
-
Tang Q, Qin D, Lv Z, Zhu X, Ma X, Yan Q, Zeng Y, Guo Y, Feng N, Lu C, 2012: Herpes simplex virus type 2 triggers reactivation of Kaposi's sarcoma-associated herpesvirus from latency and collaborates with HIV-1 Tat[J]. PLoS ONE, 7, e31652-. doi: 10.1371/journal.pone.0031652
-
Tomkowicz B, Singh SP, Cartas M, Srinivasan A, 2002: Human herpesvirus-8 encoded Kaposin: subcellular localization using immunofluorescence and biochemical approaches[J]. DNA Cell Biol, 21, 151-162. doi: 10.1089/10445490252925413
-
Toth Z, Maglinte DT, Lee SH, Lee HR, Wong LY, Brulois KF, Lee S, Buckley JD, Laird PW, Marquez VE, Jung JU, 2010: Epigenetic analysis of KSHV latent and lytic genomes[J]. PLoS Pathog, 6, e1001013-. doi: 10.1371/journal.ppat.1001013
-
Toth Z, Brulois K, Jung JU, 2013a: The chromatin landscape of Kaposi's sarcoma-associated herpesvirus[J]. Viruses, 5, 1346-1373. doi: 10.3390/v5051346
-
Toth Z, Brulois K, Lee HR, Izumiya Y, Tepper C, Kung HJ, Jung JU, 2013b: Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection[J]. PLoS Pathog, 9, e1003813-. doi: 10.1371/journal.ppat.1003813
-
Toth Z, Papp B, Brulois K, Choi YJ, Gao SJ, Jung JU, 2016: LANA-mediated recruitment of host polycomb repressive complexes onto the KSHV genome during de novo infection[J]. PLoS Pathog, 12, e1005878-. doi: 10.1371/journal.ppat.1005878
-
Tsai WH, Wang PW, Lin SY, Wu IL, Ko YC, Chen YL, Li M, Lin SF, 2012: Ser-634 and Ser-636 of Kaposi's sarcoma-associated herpesvirus RTA are involved in transactivation and are potential Cdk9 phosphorylation sites[J]. Front Microbiol, 3, 60-.
-
Tsuyama T, Tada S, Watanabe S, Seki M, Enomoto T, 2005: Licensing for DNA replication requires a strict sequential assembly of Cdc6 and Cdt1 onto chromatin in Xenopus egg extracts[J]. Nucleic Acids Res, 33, 765-775. doi: 10.1093/nar/gki226
-
Tunnicliffe RB, Schacht M, Levy C, Jowitt TA, Sandri-Goldin RM, Golovanov AP, 2015: The structure of the folded domain from the signature multifunctional protein ICP27 from herpes simplex virus-1 reveals an intertwined dimer[J]. Sci Rep, 5, 11234-. doi: 10.1038/srep11234
-
Tunnicliffe RB, Collins RF, Ruiz Nivia HD, Sandri-Goldin RM, Golovanov AP, 2018: The ICP27 homology domain of the human cytomegalovirus protein UL69 adopts a dimer-of-dimers structure[J]. MBio, 9, e01112-e01118.
-
Uldrick TS, Wang V, O'Mahony D, Aleman K, Wyvill KM, Marshall V, Steinberg SM, Pittaluga S, Maric I, Whitby D, Tosato G, Little RF, Yarchoan R, 2010: An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease[J]. Clin Infect Dis, 51, 350-358. doi: 10.1086/652977
-
Uppal T, Banerjee S, Sun Z, Verma SC, Robertson ES, 2014: KSHV LANA-the master regulator of KSHV latency[J]. Viruses, 6, 4961-4998. doi: 10.3390/v6124961
-
Van Bortle K, Corces VG, 2013a: The role of chromatin insulators in nuclear architecture and genome function[J]. Curr Opin Genet Dev, 23, 212-218. doi: 10.1016/j.gde.2012.11.003
-
Van Bortle K, Corces VG, 2013b: Spinning the web of cell fate[J]. Cell, 152, 1213-1217. doi: 10.1016/j.cell.2013.02.052
-
Van Dross R, Yao S, Asad S, Westlake G, Mays DJ, Barquero L, Duell S, Pietenpol JA, Browning PJ, 2005: Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells[J]. J Natl Cancer Inst, 97, 656-666. doi: 10.1093/jnci/dji113
-
Veettil MV, Bandyopadhyay C, Dutta D, Chandran B, 2014: Interaction of KSHV with host cell surface receptors and cell entry[J]. Viruses, 6, 4024-4046. doi: 10.3390/v6104024
-
Verma SC, Borah S, Robertson ES, 2004: Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1[J]. J Virol, 78, 10348-10359. doi: 10.1128/JVI.78.19.10348-10359.2004
-
Verma SC, Choudhuri T, Robertson ES, 2007a: The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner[J]. J Virol, 81, 3402-3413. doi: 10.1128/JVI.01607-06
-
Verma SC, Lan K, Choudhuri T, Cotter MA, Robertson ES, 2007b: An autonomous replicating element within the KSHV genome[J]. Cell Host Microbe, 2, 106-118. doi: 10.1016/j.chom.2007.07.002
-
Verma SC, Lu J, Cai Q, Kosiyatrakul S, McDowell ME, Schildkraut CL, Robertson ES, 2011: Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication[J]. PLoS Pathog, 7, e1002365-. doi: 10.1371/journal.ppat.1002365
-
Wang FZ, Akula SM, Pramod NP, Zeng L, Chandran B, 2001: Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate[J]. J Virol, 75, 7517-7527. doi: 10.1128/JVI.75.16.7517-7527.2001
-
Wang SE, Wu FY, Yu Y, Hayward GS, 2003: CCAAT/enhancer-binding protein is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters[J]. J Virol, 77, 9590-9612. doi: 10.1128/JVI.77.17.9590-9612.2003
-
Wang X, He B, Zhang Z, Liu T, Wang H, Li X, Zhang Q, Lan K, Lu X, Wen H, 2010: Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors[J]. Virol J, 7, 62-. doi: 10.1186/1743-422X-7-62
-
Wang Y, Sathish N, Hollow C, Yuan Y, 2011: Functional characterization of Kaposi's sarcoma-associated herpesvirus open reading frame K8 by bacterial artificial chromosome-based mutagenesis[J]. J Virol, 85, 1943-1957. doi: 10.1128/JVI.02060-10
-
Wang L, Kang G, Kumar P, Lu W, Li Y, Zhou Y, Li Q, Wood C, 2014: Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection[J]. Proc Natl Acad Sci USA, 111, 3146-3151. doi: 10.1073/pnas.1318175111
-
Wang F, Guo Y, Li W, Lu C, Yan Q, 2018: Generation of a KSHV K13 deletion mutant for vFLIP function study[J]. J Med Virol, 90, 753-760. doi: 10.1002/jmv.v90.4
-
Wen KW, Damania B, 2010: Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis[J]. Cancer Lett, 289, 140-150. doi: 10.1016/j.canlet.2009.07.004
-
Wen HJ, Minhas V, Wood C, 2009: Identification and characterization of a new Kaposi's sarcoma-associated herpesvirus replication and transcription activator (RTA)-responsive element involved in RTA-mediated transactivation[J]. J Gen Virol, 90, 944-953. doi: 10.1099/vir.2008.006817-0
-
Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FEA, Aldam DM, Denton AS, Miller RF, Weller IVD, Weiss RA, Tedder RS, Schulz TF, 1995: Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma[J]. Lancet, 346, 799-802. doi: 10.1016/S0140-6736(95)91619-9
-
Woodard C, Shamay M, Liao G, Zhu J, Ng AN, Li R, Newman R, Rho HS, Hu J, Wan J, Qian J, Zhu H, 2012: Phosphorylation of the chromatin binding domain of KSHV LANA[J]. PLoS Pathog, 8, e1002972-. doi: 10.1371/journal.ppat.1002972
-
Wu J, Xu Y, Mo D, Huang P, Sun R, Huang L, Pan S, Xu J, 2014: Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 promotes cell proliferation and migration by upregulating DNMT1 via STAT3 activation[J]. PLoS ONE, 9, e93478-. doi: 10.1371/journal.pone.0093478
-
Wu JJ, Li W, Shao Y, Avey D, Fu B, Gillen J, Hand T, Ma S, Liu X, Miley W, Konrad A, Neipel F, Sturzl M, Whitby D, Li H, Zhu F, 2015: Inhibition of cGAS DNA sensing by a herpesvirus virion protein[J]. Cell Host Microbe, 18, 333-344. doi: 10.1016/j.chom.2015.07.015
-
Xiao B, Verma SC, Cai Q, Kaul R, Lu J, Saha A, Robertson ES, 2010: Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores[J]. J Virol, 84, 9718-9732. doi: 10.1128/JVI.00713-10
-
Xie J, Ajibade AO, Ye F, Kuhne K, Gao SJ, 2005: Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways[J]. Virology, 371, 139-154.
-
Yamanegi K, Tang S, Zheng ZM, 2005: Kaposi's sarcoma-associated herpesvirus K8beta is derived from a spliced intermediate of K8 pre-mRNA and antagonizes K8alpha (K-bZIP) to induce p21 and p53 and blocks K8alpha-CDK2 interaction[J]. J Virol, 79, 14207-14221. doi: 10.1128/JVI.79.22.14207-14221.2005
-
Ye F, 2017: RNA N6-adenosine methylation (m6A) steers epitranscriptomic control of herpesvirus replication[J]. Inflamm Cell Signal, 4, e1604-.
-
Ye F, Zhou F, Xie J, Kang T, Greene W, Kuhne K, Lei X, Li Q, Gao SJ, 2008: Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency[J]. J Virol, 82, 4235-4249. doi: 10.1128/JVI.02370-07
-
Ye F, Lei X, Gao SJ, 2011a: Mechanisms of Kaposi's Sarcoma-associated herpesvirus latency and reactivation[J]. Adv Virol, 2011, 193860-.
-
Ye F, Zhou F, Bedolla RG, Jones T, Lei X, Kang T, Guadalupe M, Gao SJ, 2011b: Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency[J]. PLoS Pathog, 7, e1002054-. doi: 10.1371/journal.ppat.1002054
-
Ye F, Zhou F, Nithianantham S, Chandran B, Yu X, Weinberg A, Gao SJ, 2013: Kaposi's sarcoma-associated herpesvirus induces rapid release of angiopoietin-2 from endothelial cells[J]. J Virol, 87, 6326-6335. doi: 10.1128/JVI.03303-12
-
Ye F, Chen ER, Nilsen TW, 2017: Kaposi's sarcoma-associated herpesvirus utilizes and manipulates RNA N6-Adenosine methylation to promote lytic replication[J]. J Virol, 91, e00466-00417.
-
Yu F, Harada JN, Brown HJ, Deng H, Song MJ, Wu TT, Kato-Stankiewicz J, Nelson CG, Vieira J, Tamanoi F, Chanda SK, Sun R, 2007: Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus[J]. PLoS Pathog, 3, e44-. doi: 10.1371/journal.ppat.0030044
-
Yuan F, Gao ZQ, Majerciak V, Bai L, Hu ML, Lin XX, Zheng ZM, Dong YH, Lan K, 2018: The crystal structure of KSHV ORF57 reveals dimeric active sites important for protein stability and function[J]. PLoS Pathog, 14, e1007232-. doi: 10.1371/journal.ppat.1007232
-
Zhang T, Liu Z, Wang J, Minhas V, Wood C, Clifford GM, He N, Franceschi S, 2017: Seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus among HIV-negative people in China[J]. Infect Agent Cancer, 12, 32-. doi: 10.1186/s13027-017-0142-9
-
Zhao Q, Liang D, Sun R, Jia B, Xia T, Xiao H, Lan K, 2015: Kaposi's sarcoma-associated herpesvirus-encoded replication and transcription activator impairs innate immunity via ubiquitin-mediated degradation of myeloid differentiation factor 88[J]. J Virol, 89, 415-427. doi: 10.1128/JVI.02591-14
-
Zheng ZM, 2003: Split genes and their expression in Kaposi's sarcoma-associated herpesvirus[J]. Rev Med Virol, 13, 173-184. doi: 10.1002/(ISSN)1099-1654
-
Zheng J, Yang Y, Cui M, Shu ZJ, Han LL, Liu ZQ, Wood C, Zhang T, Zeng Y, 2017: Prevalence of Kaposi's sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China[J]. Virol Sin, 32, 396-403. doi: 10.1007/s12250-017-4049-9
-
Zhou FC, Zhang YJ, Deng JH, Wang XP, Pan HY, Hettler E, Gao SJ, 2002: Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis[J]. J Virol, 76, 6185-6196. doi: 10.1128/JVI.76.12.6185-6196.2002
-
Zhu FX, Cusano T, Yuan Y, 1999: Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus[J]. J Virol, 73, 5556-5567.
-
Zhu FX, Chong JM, Wu L, Yuan Y, 2005: Virion proteins of Kaposi's sarcoma-associated herpesvirus[J]. J Virol, 79, 800-811. doi: 10.1128/JVI.79.2.800-811.2005
-
Ziegelbauer JM, Sullivan CS, Ganem D, 2009: Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs[J]. Nat Genet, 41, 130-134. doi: 10.1038/ng.266
-
Zoetweij JP, Moses A, Rinderknecht AS, Davis DA, Overwijk WW, Yarchoan R, Orenstein JM, Blauvelt A, 2000: Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus[J]. Blood, 97, 2374-2379.